{
  "disease_name": "Neuroblastoma",
  "synonyms": [
    "NB"
  ],
  "summary": "Neuroblastoma is a type of cancer that forms in certain types of nerve tissue, most frequently starting from one of the adrenal glands but can also develop in the head, neck, chest, abdomen, or spine. It is the most common cancer in babies and the third-most common cancer in children.",
  "causes": [
    "Genetic mutation occurring in the first trimester of pregnancy",
    "Inherited mutation",
    "Germline mutations in the anaplastic lymphoma kinase (ALK) gene",
    "Germline mutations in the PHOX2B gene",
    "Germline mutations in the KIF1B gene",
    "MYCN oncogene amplification",
    "Duplicated segments of the LMO1 gene",
    "Copy-number variation within the NBPF10 gene",
    "Excessively expressed miRNAs in 1p-deleted neuroblastoma cells"
  ],
  "risk_factors": [
    "Parental factors around conception and during gestation",
    "Occupation (exposure to chemicals in specific industries)",
    "Smoking",
    "Alcohol consumption",
    "Use of medicinal drugs during pregnancy",
    "Birth factors",
    "Atopy",
    "Exposure to infection early in life",
    "Use of hormones and fertility drugs",
    "Maternal use of hair dye"
  ],
  "symptoms": [
    "Bone pain",
    "Lump in the abdomen, neck, or chest",
    "Painless, bluish lump under the skin",
    "Fatigue",
    "Loss of appetite",
    "Fever",
    "Joint pain",
    "Abdominal distension",
    "Constipation",
    "Breathing problems",
    "Weakness",
    "Inability to stand, crawl, or walk",
    "Limping",
    "Bruising around the eyes",
    "Swelling around the eyes",
    "Pallor from anemia",
    "Bulging eyes",
    "Dark circles around the eyes",
    "Swollen stomach",
    "Trouble breathing in babies",
    "Paralysis"
  ],
  "diagnosis": [
    "Tissue biopsy",
    "Ultrasound during pregnancy",
    "Surgical pathologist evaluation",
    "Microscopic findings",
    "Laboratory tests",
    "Elevated levels of catecholamines or their metabolites in urine or blood (dopamine, homovanillic acid (HVA), vanillylmandelic acid (VMA))",
    "Meta-iodobenzylguanidine (mIBG) scan",
    "Fluoro-deoxy-glucose â€“ positron emission tomography (F-FDG-PET)",
    "Microscopy (small, round, blue tumor cells, Homer Wright pseudorosettes)",
    "Immunohistochemical stains",
    "International Neuroblastoma Staging System (INSS)",
    "International Neuroblastoma Risk Group (INRG) classification system",
    "International Neuroblastoma Risk Group Staging System (INRGSS)",
    "Medical history",
    "Neurological exam",
    "Imaging tests (x-rays, CT scan, ultrasound, MRI)",
    "Blood and urine tests",
    "Bone marrow aspiration and biopsy"
  ],
  "treatments": [
    "Observation",
    "Surgery",
    "Radiation therapy",
    "Chemotherapy",
    "Stem cell transplantation",
    "Differentiation agent isotretinoin (13-cis-retinoic acid)",
    "Immunotherapy with anti-GD2 monoclonal antibody therapy (dinutuximab)",
    "High-dose chemotherapy and radiation therapy with stem cell rescue",
    "Iodine 131-MIBG therapy",
    "Targeted therapy",
    "Myeloablative therapy",
    "Platinum compounds (cisplatin, carboplatin)",
    "Alkylating agents (cyclophosphamide, ifosfamide, melphalan)",
    "Topoisomerase II inhibitor (etoposide)",
    "Anthracycline antibiotics (doxorubicin)",
    "Vinca alkaloids (vincristine)",
    "Topoisomerase I inhibitors (topotecan, irinotecan)",
    "Epigenetic therapies",
    "Naxitamab",
    "Granulocyte-macrophage colony-stimulating factor (GM-CSF)",
    "Interleukin-2 (IL-2)",
    "177Lu-DOTA-TATE (radionuclide therapy)",
    "Haploidentical stem cell transplant"
  ],
  "related_genes": [
    "ALK",
    "PHOX2B",
    "KIF1B",
    "MYCN",
    "LMO1",
    "AHCY",
    "DPYSL3",
    "NME1",
    "NBPF1",
    "miR-495"
  ],
  "subtypes": [
    "Low-risk neuroblastoma",
    "Intermediate-risk neuroblastoma",
    "High-risk neuroblastoma",
    "Esthesioneuroblastoma (olfactory neuroblastoma)",
    "Peripheral neuroblastic tumors (pNTs)",
    "Ganglioneuroma",
    "Ganglioneuroblastoma",
    "Stage 1",
    "Stage 2A",
    "Stage 2B",
    "Stage 3",
    "Stage 4",
    "Stage 4S",
    "Stage L1",
    "Stage L2",
    "Stage M",
    "Stage MS",
    "Very low risk",
    "Low risk",
    "Intermediate risk",
    "High risk",
    "Subtype 1",
    "Subtype 2A",
    "Subtype 2B"
  ]
}